Abrocitinib
Abrocitinib ne na baka, ƙananan kwayoyin halitta, Janus kinase (JAK) 1 mai hanawa a cikin ci gaba don kula da manya da matasa tare da matsakaicin matsakaici zuwa mai tsanani atopic dermatitis.
Abrocitinib yana ƙarƙashin bincike a gwaji na asibiti NCT03796676 (JAK1 Inhibitor With Medicated Topical Therapy a cikin Matasa Tare da Atopic Dermatitis).
A halin yanzu Pfizer yana haɓaka Abrocitinib don maganin cututtukan cututtukan fata (eczema).Mai hanawa Janus kinase 1 (JAK1) ne na baka sau ɗaya kowace rana.
Atopic dermatitis (AD) cuta ce mai rikitarwa, na yau da kullun, mai kumburin fata wanda ke da alaƙa da pruritic, matsanancin ƙaiƙayi, da raunukan eczematous wanda ke shafar kusan 25% na yara da 2% zuwa 3% na manya a duniya.Abrocitinib shine mai hanawa na Janus kinase-1 (JAK1) enzyme wanda ke hana tsarin kumburi.Sabili da haka, mun yi niyya don tantance inganci da amincin abrocitinib don matsakaici-to-mai tsanani AD.
Abrocitinib a cikin kashi 100 MG ko 200 MG yana da tasiri, jurewa, kuma magani mai ban sha'awa a cikin zalunta marasa lafiya tare da matsakaici-zuwa mai tsanani atopic dermatitis.Duk da haka, bincike ya fi dacewa da tasiri na abrocitinib 200 MG akan 100 MG, amma sakamako masu illa irin su tashin zuciya da ciwon kai suna iya faruwa fiye da 200 MG.
Shawara18Ayyukan Ƙididdigar Ƙirar Ƙirar da aka amince da su4, kuma6ayyukan suna ƙarƙashin amincewa.
Babban tsarin kula da ingancin ingancin ƙasa ya kafa tushe mai ƙarfi don siyarwa.
Ingantacciyar kulawa tana gudanar da duk tsawon rayuwar samfurin don tabbatar da inganci da tasirin warkewa.
Mawakan da ake gudanarwa na kwararru yana tallafawa ingancin bukatun yayin aikace-aikacen da rajista.
Layin Packaging Bottled na Koriya Countec
Layin Marufi na CVC Taiwan
Layin Marufi na Hukumar CAM Italiya
Jamus Fette Compacting Machine
Japan Viswill Tablet Detector
Dakin Kulawa na DCS
